Dr. Ruth R. Sarmiento, MD

Dr. Sarmiento practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Sarmiento's NPI, 1609893072, was assigned on July 16, 2006. Dr. Sarmiento holds Georgia license 037065.

Dr. Sarmiento's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Sarmiento's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Sarmiento is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Northside Hospital Cancer Institute. Dmand AI also links Dr. Sarmiento to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sarmiento practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sarmiento's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sarmiento is licensed in Georgia.

CMS data shows 362 Medicare services from Dr. Sarmiento across 5 procedure codes in 2024, for 192 Medicare patients. Medicare paid $17,206 for them.

CMS counts 192 Medicare patients who saw Dr. Sarmiento in 2024. The largest group is 75 to 84, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sarmiento's median patient age at 67, with 66% women.

In 2024, Dr. Sarmiento wrote 777 Medicare Part D claims for 153 patients. 67% of them were for generic drugs. CMS names the drug for 592 of them, across 22 drugs with 11 or more claims each, at $2,876,691 in total drug cost. In 2023, CMS named 346 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Sarmiento for performance year 2024, reported as part of a group. Dr. Sarmiento accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 214 general payments to Dr. Sarmiento from 59 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novartis Pharmaceuticals Corporation paid the most, $451.